Key result
Preincubation of epetraborole with E. coli leucyl-tRNA synthetase decreased the IC50 from 38 to 3 nM, and adding sub-MIC tobramycin increased the postantibiotic effect from 0.88 to 1.70-3 hours.
Why the study?
To assess the vulnerability of Escherichia coli leucyl-tRNA synthetase by studying its time-dependent inhibition by benzoxaborole compounds, providing insight into target vulnerability and the postantibiotic effect.
The study demonstrates that benzoxaboroles exhibit time-dependent inhibition of ecLeuRS, and their postantibiotic effect is prolonged when protein turnover is reduced by sub-MIC tobramycin.
Does not support clinical use of epetraborole-tobramycin combinations; leaves open need for in vivo validation.
The postantibiotic effect (PAE) is the persistent suppression of microbial growth following the removal of antimicrobial therapy. In general, antibiotics that generate a PAE are dosed less frequently, and thus, the PAE has important implications for dosing regimens. PAEs can arise through several mechanisms, including the extended occupancy of the drug target following drug elimination, and the correlation between drug-target residence time and PAE provides insight into target vulnerability. To assess the vulnerability of Escherichia coli leucyl-tRNA synthetase (ecLeuRS), which is an essential enzyme in protein synthesis, the time-dependent inhibition of the enzyme was studied by the benzoxaborole class of compounds that inhibit LeuRS by forming a stable LeuRS-tRNA Leu -benzoxaborole adduct. Preincubation of epetraborole with ecLeuRS resulted in a decrease in the IC 50 value for enzyme inhibition from 38 to 3 nM, consistent with the slow formation of the final enzyme–inhibitor complex, and similar shifts in IC 50 were observed for three other benzoxaboroles. The benzoxaboroles generated short PAEs (<1 h) in E. coli, however, the PAE values of AN3334 and epetraborole increased from 0.88 to 1.70–3 h when a sub-MIC concentration of the aminoglycoside tobramycin was included in the media. pSILAC revealed that the synthesis rate of ecLeuRS was reduced 1.6-fold in the presence of sub-MIC tobramycin, reinforcing the role that protein turnover plays in target vulnerability.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question. Benzoxaboroles (epetraborole, AN3334) was evaluated on IC50 for enzyme inhibition and postantibiotic effect (PAE). Preincubation of epetraborole with E. coli leucyl-tRNA synthetase decreased the IC50 from 38 to 3 nM, and adding sub-MIC tobramycin increased the postantibiotic effect from 0.88 to 1.70-3 hours.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: